Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08).
about
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Neoadjuvant radiotherapy combi ...... phase I/II trial (SAKK 41/08).
@en
Neoadjuvant radiotherapy combi ...... tal cancer: A phase I/II trial
@nl
type
label
Neoadjuvant radiotherapy combi ...... phase I/II trial (SAKK 41/08).
@en
Neoadjuvant radiotherapy combi ...... tal cancer: A phase I/II trial
@nl
prefLabel
Neoadjuvant radiotherapy combi ...... phase I/II trial (SAKK 41/08).
@en
Neoadjuvant radiotherapy combi ...... tal cancer: A phase I/II trial
@nl
P2093
P921
P1476
Neoadjuvant radiotherapy combi ...... phase I/II trial (SAKK 41/08).
@en
P2093
Arnaud Roth
Daniel Rauch
Daniel Zwahlen
Daniela Bärtschi
Dieter Koeberle
György Bodoky
Kathrin Zaugg
Ludwig Plasswilm
Martin D Berger
Panagiotis Samaras
P356
10.1016/J.EJCA.2017.11.005
P577
2017-12-11T00:00:00Z